AU2039800A - 5-membered heterocycles for the treatment of human diseases involving modulatorsof selectins - Google Patents
5-membered heterocycles for the treatment of human diseases involving modulatorsof selectinsInfo
- Publication number
- AU2039800A AU2039800A AU20398/00A AU2039800A AU2039800A AU 2039800 A AU2039800 A AU 2039800A AU 20398/00 A AU20398/00 A AU 20398/00A AU 2039800 A AU2039800 A AU 2039800A AU 2039800 A AU2039800 A AU 2039800A
- Authority
- AU
- Australia
- Prior art keywords
- modulatorsof
- selectins
- treatment
- human diseases
- diseases involving
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11102698P | 1998-12-04 | 1998-12-04 | |
| US11102598P | 1998-12-04 | 1998-12-04 | |
| US60111025 | 1998-12-04 | ||
| US60111026 | 1998-12-04 | ||
| PCT/US1999/028692 WO2000033836A1 (en) | 1998-12-04 | 1999-12-03 | 5-membered heterocycles for the treatment of human diseases involving modulators of selectins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2039800A true AU2039800A (en) | 2000-06-26 |
Family
ID=26808588
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU21643/00A Abandoned AU2164300A (en) | 1998-12-04 | 1999-12-03 | Substituted thiazoles for treatment of human diseases involving modulators of p-, l- and e- selectin |
| AU20398/00A Abandoned AU2039800A (en) | 1998-12-04 | 1999-12-03 | 5-membered heterocycles for the treatment of human diseases involving modulatorsof selectins |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU21643/00A Abandoned AU2164300A (en) | 1998-12-04 | 1999-12-03 | Substituted thiazoles for treatment of human diseases involving modulators of p-, l- and e- selectin |
Country Status (2)
| Country | Link |
|---|---|
| AU (2) | AU2164300A (en) |
| WO (2) | WO2000033836A1 (en) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2352957A1 (en) | 1999-09-29 | 2001-04-05 | Ortho-Mcneil Pharmaceutical, Inc. | Isonipecotamides for the treatment of integrin-mediated disorders |
| BR0015532A (en) | 1999-11-22 | 2002-06-25 | Smithkline Beecham Plc | Compounds |
| GB0028383D0 (en) | 2000-11-21 | 2001-01-03 | Novartis Ag | Organic compounds |
| AU2002319627A1 (en) | 2001-07-20 | 2003-03-03 | Merck And Co., Inc. | Substituted imidazoles as cannabinoid receptor modulators |
| WO2003059880A1 (en) | 2002-01-11 | 2003-07-24 | Sankyo Company, Limited | Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |
| ES2497116T3 (en) | 2002-08-19 | 2014-09-22 | Lorus Therapeutics Inc. | 2,4,5-trisubstituted imidazoles and their use as antimicrobial agents |
| DK1644363T3 (en) | 2003-05-30 | 2012-05-29 | Gemin X Pharmaceuticals Canada Inc | Triheterocyclic compounds, compositions and methods for the treatment of cancer or viral diseases |
| CA2545942C (en) | 2003-11-14 | 2012-07-10 | Lorus Therapeutics Inc. | Aryl imidazoles and their use as anti-cancer agents |
| US20050148601A1 (en) * | 2003-12-19 | 2005-07-07 | Maynard George D. | Neurokinin-3 receptor modulators: diaryl imidazole derivatives |
| JP2007519727A (en) | 2004-01-23 | 2007-07-19 | ネレアス ファーマシューティカルズ インコーポレイテッド | Bis-indolepyrrole useful as an antibacterial agent |
| CA2557536C (en) | 2004-02-24 | 2010-07-13 | Sankyo Company Limited | Amino alcohol compound |
| EP1577289A1 (en) | 2004-03-18 | 2005-09-21 | Revotar Biopharmaceuticals AG | Non-glycosylated/-glycosidic/-peptidic small molecule selectin inhibitors for the treament of inflammatory disorders |
| US8148392B2 (en) | 2005-05-25 | 2012-04-03 | Lorus Therapeutics Inc. | 2-indolyl imidazo [4,5-d] phenanthroline derivatives and their use in the treatment of cancer |
| EP1764095A1 (en) | 2005-09-20 | 2007-03-21 | Revotar Biopharmaceuticals AG | Novel nitrocatechol derivatives having selectin ligand activity |
| EP1764096A1 (en) | 2005-09-20 | 2007-03-21 | Revotar Biopharmaceuticals AG | Novel phloroglucinol derivatives having selectin ligand activity |
| EP1764093A1 (en) | 2005-09-20 | 2007-03-21 | Revotar Biopharmaceuticals AG | Novel aromatic compounds and their use in medical applications |
| BRPI0719122A2 (en) | 2006-08-24 | 2013-12-10 | Novartis Ag | ORGANIC COMPOUNDS |
| CA2662574A1 (en) | 2006-09-22 | 2008-03-27 | Novartis Ag | Heterocyclic organic compounds |
| EA200900820A1 (en) | 2006-12-20 | 2010-02-26 | Новартис Аг | 2-substituted 5-member heterocycles as stearaoyl-soa-desaturase inhibitors (SSDs) |
| JP2012505892A (en) | 2008-10-15 | 2012-03-08 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Condensed heteroaryl diamide compounds useful as MMP-13 inhibitors |
| WO2010045188A1 (en) | 2008-10-17 | 2010-04-22 | Boehringer Ingelheim International Gmbh | Heteroaryl substituted indole compounds useful as mmp-13 inhibitors |
| AU2010221650B2 (en) * | 2009-03-04 | 2015-06-25 | Merck Sharp & Dohme Corp. | Imidazole derivatives useful as modulators of FAAH and as FAAH imaging agents |
| CN102482249B (en) | 2009-07-08 | 2016-06-08 | 德米拉(加拿大)公司 | For treating the TOFA analog of skin disorder or morbid state |
| CN104603118B (en) | 2012-05-31 | 2017-10-03 | 菲尼克斯药品股份公司 | It is used as the thiazole and related derivatives through formamide or sulfonamide substitutions of orphan nuclear receptor ROR γ instrumentalities |
| AU2014235962A1 (en) | 2013-03-20 | 2015-09-10 | Aptose Biosciences Inc. | 2-substituted imidazo[4,5-d]phenanthroline derivatives and their use in the treatment of cancer |
| US9567643B2 (en) | 2013-10-04 | 2017-02-14 | Aptose Biosciences Inc. | Compositions and methods for treating cancers |
| TW201936190A (en) | 2017-10-30 | 2019-09-16 | 加拿大商艾普托斯生物科學公司 | Aryl imidazoles for the treatment of cancer |
| CN114105881B (en) * | 2020-08-31 | 2024-01-26 | 沈阳海诺威医药科技有限公司 | Platelet aggregation inhibitor, and preparation method and application thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3002989A1 (en) * | 1980-01-29 | 1981-07-30 | Hoechst Ag, 6000 Frankfurt | HYDROXYPHENYL-THIAZOLE, -THIAZOLINE AND -THIAZOLIDINE-CARBONIC ACIDS, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE FOR INFLUENCING COLLAGEN METABOLISM |
| US5753687A (en) * | 1995-06-19 | 1998-05-19 | Ontogen Corporation | Modulators of proteins with phosphotryrosine recognition units |
-
1999
- 1999-12-03 WO PCT/US1999/028692 patent/WO2000033836A1/en active Application Filing
- 1999-12-03 AU AU21643/00A patent/AU2164300A/en not_active Abandoned
- 1999-12-03 WO PCT/US1999/028694 patent/WO2000034255A1/en active Application Filing
- 1999-12-03 AU AU20398/00A patent/AU2039800A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000034255A9 (en) | 2001-10-04 |
| WO2000034255A1 (en) | 2000-06-15 |
| WO2000033836A9 (en) | 2001-10-04 |
| AU2164300A (en) | 2000-06-26 |
| WO2000033836A1 (en) | 2000-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2039800A (en) | 5-membered heterocycles for the treatment of human diseases involving modulatorsof selectins | |
| AU698509B2 (en) | Compositions for the treatment of rheumatoid-based arthritic diseases | |
| AU2072201A (en) | Agents and methods for the treatment of proliferative diseases | |
| AU7622000A (en) | Compounds for the treatment of viral-mediated diseases | |
| AU3596199A (en) | Treatment of celiac disease | |
| EP1144639A3 (en) | Compounds and methods for the diagnosis and treatment of ehrlichia infection | |
| AU3632600A (en) | Compositions and methods for the treatment of immune related diseases | |
| AU3167499A (en) | Human body cleaner | |
| AU3784999A (en) | Methods for treatment of pain | |
| IL129144A0 (en) | Use of 1-hydroxy-2-pyridones for the treatment of skin diseases | |
| HUP0104963A3 (en) | Compositions for the treatment of skin diseases | |
| AU3896900A (en) | Treatment of pain | |
| AU2021601A (en) | Composition for the treatment of dandruff | |
| AU9278598A (en) | Use of azole derivatives for the treatment of inflammatory skin conditions | |
| AU3434601A (en) | Compositions and methods for the treatment of immune related diseases | |
| AU3760900A (en) | Treatment of menstrual function | |
| AU2566201A (en) | Compounds and methods for the treatment of pain | |
| IL135994A0 (en) | Combination therapy for the treatment of aids | |
| AU1405001A (en) | Treatment of diseases | |
| AU1022501A (en) | Use of compositions for the caring treatment of the skin | |
| AU2462097A (en) | The use of a substance p antagonist for the manufacture of medicament for the treatment of ocular pain | |
| AU3501100A (en) | Synergistic combination for treatment of viral-mediated diseases | |
| AU3212099A (en) | Method for increasing the permeability of horny human tissue | |
| AUPQ048899A0 (en) | A method for the diagnosis and treatment of cancer and agents useful therefor | |
| AU6288698A (en) | Apparatus for stimulating the human body |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |